| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2285703C Detection of dna damaging agents |
| 02/08/2011 | CA2275404C Method for determining the prognosis of a patient with a neurological disease |
| 02/08/2011 | CA2260363C Polynucleotide and its use for modulating a defence response in plants |
| 02/08/2011 | CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/07/2011 | CA2712125A1 Method and apparatus for testing slurry penetration through mat facer in gypsum-based panel production |
| 02/03/2011 | WO2011014885A1 Thermostable type-a dna polymerase mutants with increased polymerization rate and resistance to inhibitors |
| 02/03/2011 | WO2011014882A1 CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS |
| 02/03/2011 | WO2011014879A2 Assay tools and methods of use |
| 02/03/2011 | WO2011014866A1 Materials and methods for diagnosing and treating shellfish allergy |
| 02/03/2011 | WO2011014845A1 Screening system to identify patterns on substrate surfaces for inducing stem cell differentiation and producing homogenous population of a desired cell type |
| 02/03/2011 | WO2011014821A1 Folate-targeted diagnostics and treatment |
| 02/03/2011 | WO2011014811A1 Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| 02/03/2011 | WO2011014763A1 Device for detection of antigens and uses thereof |
| 02/03/2011 | WO2011014750A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | WO2011014733A1 Intein-based fluorescent bio-circuit for vitamin d detection |
| 02/03/2011 | WO2011014721A2 Genetically modified rat models for pharmacokinetics |
| 02/03/2011 | WO2011014697A1 Methods of assessing a risk of cancer progression |
| 02/03/2011 | WO2011014674A2 Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof |
| 02/03/2011 | WO2011014673A1 Automated lateral flow immunoassay cassette with improved flow properties |
| 02/03/2011 | WO2011014659A2 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | WO2011014648A2 METHODS AND SYSTEM FOR DETECTING SOLUBLE AMYLOID-β |
| 02/03/2011 | WO2011014485A2 Methods to characterize cell reprogramming and uses thereof |
| 02/03/2011 | WO2011014457A1 Combination treatments |
| 02/03/2011 | WO2011014349A1 Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis |
| 02/03/2011 | WO2011014299A2 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 02/03/2011 | WO2011014051A1 A method for controlling proteolytic degradation of recombinant proteins |
| 02/03/2011 | WO2011014042A2 Method and apparatus for detecting metal ions, probe used for the same and preparation method thereof |
| 02/03/2011 | WO2011013753A1 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
| 02/03/2011 | WO2011013703A1 Pancreatic endocrine cell indicator and utilization of same |
| 02/03/2011 | WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis |
| 02/03/2011 | WO2011013378A1 Alloyed metal colloid |
| 02/03/2011 | WO2011013319A1 Technique for determining maturity of cell mass, and image processing program and image processing device which use the technique, and method for producing cell mass |
| 02/03/2011 | WO2011013123A1 Ultrasound assisted immunoassay |
| 02/03/2011 | WO2011013046A1 Method and apparatus of determining exhaled nitric oxide |
| 02/03/2011 | WO2011012962A1 Diagnosis and monitoring of mycobacterium tuberculosis infection |
| 02/03/2011 | WO2011012901A1 Method for detection of, or the risk of, bladder cancer |
| 02/03/2011 | WO2011012859A1 Sample plate |
| 02/03/2011 | WO2011012848A1 Improvements relating to sensor devices |
| 02/03/2011 | WO2011012832A2 Method for diagnosing a cancer, for determining the thrombotic risk in an individual stricken with a cancer and for determining the severity of a cancer in an individual |
| 02/03/2011 | WO2011012811A2 Novel peptidase substrates |
| 02/03/2011 | WO2011012809A2 Novel peptidase substrates |
| 02/03/2011 | WO2011012754A2 Electrochemical sensor for the detection of analytes in liquid media |
| 02/03/2011 | WO2011012672A1 New diagnostic tools for alzheimer disease |
| 02/03/2011 | WO2011012646A2 Non-invasive in vivo optical imaging method |
| 02/03/2011 | WO2011012553A1 Method for predicting the likelihood of an onset of an inflammation associated organ failure |
| 02/03/2011 | WO2011012298A1 Agonists and antagonists of human bitter taste receptor tas2r49 and uses thereof |
| 02/03/2011 | WO2011012268A1 Use of mimecan in the assessment of heart failure |
| 02/03/2011 | WO2011012098A1 Method for detecting and identifying a variant c. difficile strain in a sample |
| 02/03/2011 | WO2011012053A1 Test strip for detecting anti-cyclic citrullinated peptide antibody in blood and method of preparing the same |
| 02/03/2011 | WO2011011882A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | WO2011011823A1 Method and apparatus for conducting an assay |
| 02/03/2011 | WO2010144313A3 Non-invasive monitoring of blood metabolite levels |
| 02/03/2011 | WO2010126590A8 Ptp1b inhibitors |
| 02/03/2011 | WO2010120364A3 Impedimetric sensors using dielectric nanoparticles |
| 02/03/2011 | WO2010116003A3 Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy |
| 02/03/2011 | WO2010111215A3 Compositions and methods for treatment of hemorrhage |
| 02/03/2011 | WO2010093907A3 An assay for the detection of recurrence in breast cancer using the novel tumor suppressor dear1 |
| 02/03/2011 | WO2010054377A9 Fully human antibodies against n-cadherin |
| 02/03/2011 | WO2010009267A8 Cuvette-based apparatus for blood coagulation measurement and testing |
| 02/03/2011 | WO2010000089A8 Stat3 and tyk2 as drug targets for neurodegenerative diseases |
| 02/03/2011 | WO2009152269A3 Methods of quantifying biomarkers |
| 02/03/2011 | WO2007035872A3 Tdf-related compounds and analogs thereof |
| 02/03/2011 | WO2006053328A8 Biomarkers for screening, predicting, and monitoring prostate disease |
| 02/03/2011 | US20110030072 Genome editing of immunodeficiency genes in animals |
| 02/03/2011 | US20110030071 Transgenic Animal Model of Cancer and Methods of Use |
| 02/03/2011 | US20110030070 Diagnosis and treatment of autism using cd38 |
| 02/03/2011 | US20110029255 Drinking vessels and related systems and methods |
| 02/03/2011 | US20110029252 High confidence in positive status determination |
| 02/03/2011 | US20110029247 Exponential Sampling Of Red And Infrared Signals |
| 02/03/2011 | US20110028751 Perfluoro sulfonyl halides and related species as polymer support modifiers |
| 02/03/2011 | US20110028700 Mutant proteins and methods for producing them |
| 02/03/2011 | US20110028692 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners |
| 02/03/2011 | US20110028689 Nucleic acids that encode sodium channel |
| 02/03/2011 | US20110028538 Methods and compositions related to tr4 ligand |
| 02/03/2011 | US20110028533 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/03/2011 | US20110028511 Process for the manufacture of pharmaceutically active compounds |
| 02/03/2011 | US20110028409 Detection of anti-ribosomal p protein antibodies by means of synthetic peptides |
| 02/03/2011 | US20110028408 diagnostic molecule and therapeutic target |
| 02/03/2011 | US20110028399 Citrullinated cytokines |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110028383 Activated Forms Of Notch And Methods Based Thereon |
| 02/03/2011 | US20110028371 Hybrid copolymers |
| 02/03/2011 | US20110028351 Methods and Devices for Immobilization of Single Particles |
| 02/03/2011 | US20110028347 Support carrying an immobilized selective binding substance |
| 02/03/2011 | US20110028344 Biomarkers for endometrial disease |
| 02/03/2011 | US20110028341 Methods, devices, and systems for chemiluminescence-based microfluidic cell counting |
| 02/03/2011 | US20110028337 Nucleobase characterisation |
| 02/03/2011 | US20110027916 Detection apparatus for detecting particles |
| 02/03/2011 | US20110027915 Method of producing insoluble carrier particles, insoluble carrier particles, measurement reagent, specimen analyzing tool, and immunoturbidimetric assay |
| 02/03/2011 | US20110027914 Sample plate systems and methods |
| 02/03/2011 | US20110027913 Multiplexed nanoscale electrochemical sensors for multi-analyte detection |
| 02/03/2011 | US20110027912 Purified serum albumin, and immunological measurement method |
| 02/03/2011 | US20110027911 Solubilization and study of membrane proteins |
| 02/03/2011 | US20110027910 Screening |
| 02/03/2011 | US20110027909 Chimera Compositions and Methods of Use |
| 02/03/2011 | US20110027908 Device for detection of antigens and uses thereof |
| 02/03/2011 | US20110027907 Ssl7 mutants and uses therefor |